Global Cardiac Valve Market – Industry Trends and Forecast to 2029

Global Cardiac Valve Market, By Treatment (Cardiac Valve Repair, Cardiac Valve Replacement), Type (Mechanical Valves, Tissue/Bioprosthetic Valves, Transcatheter Heart Valves/Percutaneous Heart Valves, Others), Position (Mitral Valve Aortic Valve, Other Position), End-User (Hospital and Clinics, Specialty Centers, Cardiac Research Institute, Others)– Industry Trends and Forecast to 2029

Market Analysis and Size

The cardiac valve is a tiny hole in the heart chamber that controls the flow of heat. A cardiac valve is a one-way valve that is implanted into the heart of a patient to replace a defective native heart valve. It is a device that is used by patients who have heart problems. The heart valve ensures that blood flows in the proper direction and at the appropriate pressure. The valve's primary role is to keep blood flowing in one direction through the heart and from the heart to other regions of the body that require blood flow.

Data Bridge Market Research analyses that the cardiac valve market which was USD 9.12 billion in 2021, would rocket up to USD 21.79 billion by 2029, and is expected to undergo a CAGR of 11.50% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Market Definition

The cardiac valves allow blood to flow through the heart in only one direction. Before leaving each chamber of the heart, blood travels via a valve. These valves prevent blood from flowing backward.

Cardiac Valve Market Dynamics

Drivers

• Rise in geriatric population

The increasing number of patients suffering from cardiovascular diseases, the rising geriatric population, the increasing use of cardiac valves for blood pressure control, and rising levels of investment for the development of advanced and technologically innovative products are some of the factors that will likely boost the cardiac valve market's growth in the forecast period of 2022-2029. On the other hand, people's changing lifestyles would enhance numerous opportunities, resulting in the rise of the cardiac valve market over the projection period.

• Rise in cardiovascular diseases

The recent rise in the frequency of cardiovascular illnesses and cardiac valve disease has boosted the market's growth. Recently, technology has advanced and improved, which has resulted in improvements in cardiac valve devices, and this aspect is propelling the market forward in the forecast period. The market is also being driven by congenital cardiac disease. People's constantly changing lifestyles are also having an impact, as they are becoming more reliant on outside food and failing to take proper care of their health, which leads to a rise in the number of heart diseases, increasing market demand. In the projection period, the market would be boosted by the merger of various acquisitions.

• Increasing Popularity of Minimally Invasive Surgeries

Sedentary lifestyles, irregular eating patterns, and a growing preference for ready-to-eat food have all contributed to an increase in cholesterol and obesity cases. This is a significant market growth element for cardiac valves. A rise in the geriatric population, as well as their vulnerability to various cardiovascular illnesses, is likely to help market growth over the forecast period of 2022 to 2029.

Opportunities

People's awareness of disease diagnosis is growing, which will lead to more people seeking treatment in the medical sector, opening new possibilities for the industry. The government is enacting new regulations and increasing healthcare spending in underdeveloped areas, and individuals will provide abundant market growth potential. The market will increase rapidly in the forecast period as a result of the opportunities. Nonetheless, the introduction of new technology, the growing popularity of minimally invasive operations, and the introduction of innovative goods are projected to fuel the market's expansion in the future years.

Restraints/Challenges

The cardiac valve market is likely to be stifled by rising infection rates associated with the use of cardiac implants, as well as the high cost of cardiac valves, over the forecast period.

The market is being challenged to move forward by the government's strict product regulations. The market is being influenced by government regulations regarding medical products and their use. The lack of competent specialists for surgery can pose major health hazards to patients; yet, finding solutions to solve this quickly is posing hurdles for the market, and as a result, they will lose money during the projection period. The expensive expense of the equipment and the surgical procedure is limiting market expansion. The market is also being challenged by reimbursement concerns in order for the market value to rise.

This cardiac valve market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cardiac valve market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 impact on Cardiac Valve Market

The impact of the covid 19 on the business was felt. The medical industry was the only one unaffected by the pandemic. The populace was cared for using medical supplies during the infection, and demand for medical products surged as a result. As a result of the pandemic, demand for respiratory devices such as atomizers, life support machines, oxygen generators, and other similar items surged, as they are all used to treat pulmonary disorders. COVID 19 has resulted in the use of a variety of equipment manufacturers, including personal protective equipment such as gloves, masks, and other protective gear.

Recent Development

• September 2019 – Abbott has begun the TRILUMINATE pivotal trial for the evaluation of TriClip. TriClip is a tricuspid regurgitation treatment that uses a transcatheter tricuspid valve repair.

Global Cardiac Valve Market Scope

The cardiac valve market is segmented on the basis of type, treatment, position and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Cardiac Valve Repair
• Cardiac Valve Replacement

Position

• Mitral Valve
• Aortic Valve
• Other Position

Type

• Trans-Catheter Heart Valve
• Tissue Heart Valve
• Mechanical Heart Valve
• Others

End-user

• Cardiac Research Institute
• Hospital and Clinics
• Speciality centers
• Others

Cardiac Valve Market Regional Analysis/Insights

The cardiac valve market is analysed and market size insights and trends are provided by country, type, treatment, position and end-user as referenced above.

The countries covered in the cardiac valve market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominating the cardiac valve market due to the high prevalence of cardiac disorders along with adoption of cardiac devices and prevalence of enhanced healthcare infrastructure.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the growing number of geriatric population along with changing lifestyle and increasing medical tourism in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Cardiac Valve Market Share Analysis

The cardiac valve market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cardiac valve market.

Some of the major players operating in the cardiac valve market are:

• Medtronic (Ireland)
• LivaNova PLC (U.K)
• Abbott (U.S)
• Colibri Heart Valve (U.S)
• On-X Life Technologies Inc. (U.S)
• TTK (Chennai)
• JenaValve Technology Inc. (U.S)
• CryoLife Inc (U.S)
• Boston Scientific Corporation (U.S)
• Edwards Lifesciences Corporation (U.S)
• Symetis (Switzerland)
• Lepu Medical Technology(Beijing)Co.,Ltd. (China)
• Braile Biomédica (Brazil)
• Micro Interventional Devices, Incorporated (U.S)
• Auto Tissue Berlin GmbH (Germany)